Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 979 results.
User Information
Export Records
  1. 1.   Structural and mechanistic bases for resistance of the M66I capsid variant to lenacapavir
  2. Briganti, Lorenzo; Annamalai, Arun S; Bester, Stephanie M; Wei, Guochao; Andino-Moncada, Jonathan R; Singh, Satya P; Kleinpeter,Alexander; Tripathi, Meghna; Nguyen, Binh; Radhakrishnan, Rajalingam; Singh, Parmit K; Greenwood, Juliet; Schope, Lauren I; Haney, Reed; Huang, Szu-Wei; Freed, Eric O; Engelman, Alan N; Francis, Ashwanth C; Kvaratskhelia, Mamuka
  3. mBio. 2025, Apr 15; e0361324.
  1. 2.   Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids
  2. Coussens,Nathan; Dexheimer,Thomas; Silvers,Thomas; Sanchez,Phillip; Chen,Li; Hollingshead, Melinda G; Takebe, Naoko; Doroshow, James H; Teicher, Beverly A
  3. SLAS Discovery : advancing life sciences R & D. 2025, Apr 08; 100230.
  1. 3.   Distinct allosteric networks in CDK4 and CDK6 in the cell cycle and in drug resistance
  2. Zhang,Wengang; Bradburn, Devin; Heidebrink, Gretchen; Liu, Yonglan; Jang,Hyunbum; Nussinov,Ruth; Kõivomägi, Mardo
  3. Journal of Molecular Biology. 2025, Mar 31; 169121.
  1. 4.   Data imbalance in drug response prediction: multi-objective optimization approach in deep learning setting
  2. Narykov, Oleksandr; Zhu, Yitan; Brettin, Thomas; Evrard,Yvonne; Partin, Alexander; Xia, Fangfang; Shukla, Maulik; Vasanthakumari, Priyanka; Doroshow, James H; Stevens, Rick L
  3. Briefings in Bioinformatics. 2025, Mar 04; 26(2):
  1. 5.   ShiftScan: A tool for rapid analysis of high-throughput differential scanning fluorimetry data and compound prioritization
  2. Waterworth, Samantha C; Shenoy, Shilpa R; Sharma, Nirmala D; Wolcott,Chris; Donohue,Duncan; O'Keefe,Barry; Beutler,John
  3. Protein Science : a publication of the Protein Society. 2025, Mar; 34(3): e70055.
  1. 6.   Virologic effects of broadly neutralizing antibodies VRC01LS and VRC07-523LS on chronic HIV-1 infection
  2. Happe, Myra; Lynch, Rebecca M; Fichtenbaum, Carl J; Heath, Sonya L; Koletar, Susan L; Landovitz, Raphael J; Presti, Rachel M; Santana-Bagur, Jorge L; Tressler, Randall L; Holman, LaSonji A; Novik, Laura; Roa, Jhoanna C; Rothwell, Ro Shauna; Strom, Larisa; Wang,Jing; Hu, Zonghui; Conan-Cibotti, Michelle; Bhatnagar, Anjali M; Dwyer, Bridget; Ko, Sung Hee; Belinky, Frida; Namboodiri, Aryan M; Pandey, Janardan P; Carroll, Robin; Basappa, Manjula; Serebryannyy, Leonid; Narpala, Sandeep R; Lin, Bob C; McDermott, Adrian B; Boritz, Eli A; Capparelli, Edmund V; Coates, Emily E; Koup, Richard A; Ledgerwood, Julie E; Mascola, John R; Chen, Grace L; Tebas, Pablo
  3. JCI Insight. 2025, Feb 24; 10(4):
  1. 7.   Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids
  2. Dexheimer,Tom; Davoudi,Zahra; Coussens,Nathan; Silvers,Thomas; Morris, Joel; Takebe, Naoko; Said, Rabih; Moscow, Jeffrey A; Doroshow, James H; Teicher, Beverly A
  3. SLAS Discovery : advancing life sciences R & D. 2025, Feb 23; 100222.
  1. 8.   Drug-Linker Constructs Bearing Unique Dual-Mechanism Tubulin Binding Payloads Tethered through Cleavable and Non-Cleavable Linkers
  2. Ford, Jacob W; VanNatta, Jennifer M; Mondal, Deboprosad; Lin, Chen-Ming; Deng, Yuling; Bai, Ruoli; Hamel,Ernest; Trawick, Mary Lynn; Pinney, Kevin G
  3. Tetrahedron. 2025, Feb 01; 171
  1. 9.   Extracellular Matrix Limits Nanoparticle Diffusion and Cellular Uptake in a Tissue-Specific Manner
  2. Cahn,Devorah; Stern, Alexa; Buckenmeyer,Michael; Wolf,Matthew; Duncan, Gregg A
  3. ACS Nano. 2024, Nov 05;
  1. 10.   Perplexing paradoxical reactions: navigating the complexity of protracted tuberculosis meningitis-a case report
  2. Gooding,Megan; Hammoud, Dima A; Epling, Brian; Rocco, Joseph; Laidlaw, Elizabeth; Kuriakose,Safia; Chaturvedi, Mansi; Galindo, Frances; Ma, Stella V; Mystakelis, Harry; Poole, April; Russo, Kelly; Shah, Maunank; Malone, Joseph L; Rupert,Adam; Sereti, Irini; Manion, Maura
  3. Frontiers in Immunology. 2024, Oct 31; 15: 1441945.
  1. 11.   Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy
  2. Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp,Troy; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto,Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill
  3. International Journal of Cancer. 2024, Oct 31;
  1. 12.   Multi-objective latent space optimization of generative molecular design models
  2. Abeer, A N M Nafiz; Urban, Nathan M; Weil,Michael; Alexander, Francis J; Yoon, Byung-Jun
  3. Patterns (New York, N.Y.). 2024, Oct 11; 5(10): 101042.
  1. 13.   Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor: Aryl-hydrocarbon receptor antagonist drug combinations
  2. Dexheimer,Tom; Coussens,Nathan; Silvers,Thomas; Jones,Eric; Chen,Lily; Fang, Jianwen; Morris, Joel; Moscow, Jeffrey A; Doroshow, James H; Teicher, Beverly A
  3. SLAS Discovery : advancing life sciences R & D. 2024, Oct 01; 29(7): 100186.
  1. 14.   Naamidine A reveals a promising zinc-binding strategy for topical antifungal therapy
  2. Puumala, Emily; Nabeela, Sunna; Thornburg,Chris; Grkovic,Tanja; Uppuluri, Priya; Whitesell, Luke; O'Keefe,Barry; Robbins, Nicole; Cowen, Leah E
  3. Antimicrobial Agents and Chemotherapy. 2024, Sep 26; e0119424.
  1. 15.   Immunological properties of silica nanoparticles: a structure-activity relationship study
  2. Grunberger, Jason William; Dobrovolskaia,Marina; Ghandehari, Hamidreza
  3. Nanotoxicology. 2024, Sep 16; 1-23.
  1. 16.   Structural and virologic mechanism of the emergence of resistance to Mpro inhibitors in SARS-CoV-2
  2. Hattori, Shin-Ichiro; Bulut, Haydar; Hayashi, Hironori; Kishimoto, Naoki; Takamune, Nobutoki; Hasegawa, Kazuya; Furusawa, Yuri; Yamayoshi, Seiya; Murayama, Kazutaka; Tamamura, Hirokazu; Li,Mi; Wlodawer, Alexander; Kawaoka, Yoshihiro; Misumi, Shogo; Mitsuya, Hiroaki
  3. Proceedings of the National Academy of Sciences of the United States of America. 2024, Sep 10; 121(37): e2404175121.
  1. 17.   The SRC family kinase inhibitor NXP900 demonstrates potent anti-tumor activity in squamous cell carcinomas
  2. Dash,Sweta; Hanson, Sabrina; King, Ben; Nyswaner, Katherine; Foss, Kelcie; Tesi,Noelle; Harvey, Mungo J B; Navarro-Marchal, Saúl A; Woods, Allison; Poradosu, Enrique; Unciti-Broceta, Asier; Carragher, Neil O; Brognard,John
  3. The Journal of Biological Chemistry. 2024, Jul 30; 107615.
  1. 18.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 19.   Correlation of protein binding pocket properties with hits' chemistries used in generation of ultra-large virtual libraries
  2. Song, Robert X; Nicklaus,Marc; Tarasova,Nadya
  3. Journal of Computer-Aided Molecular Design. 2024, May 16; 38(1): 22.
  1. 20.   Slower CDK4 and faster CDK2 activation in the cell cycle
  2. Zhang,Wengang; Liu,Yonglan; Jang,Hyunbum; Nussinov,Ruth
  3. Structure (London, England : 1993). 2024, Apr 23;
  1. 21.   Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood-brain barrier
  2. Thomas, Joanna R; Frye, William J E; Robey, Robert W; Warner,Andrew; Butcher,Donna; Matta,Jennifer; Morgan,Tamara; Edmondson,Elijah; Salazar, Paula B; Ambudkar, Suresh V; Gottesman, Michael M
  3. Fluids and Barriers of the CNS. 2024, Mar 15; 21(1): 27.
  1. 22.   Carrier-Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery
  2. Quinlan, John A; Inglut, Collin T; Srivastava, Payal; Rahman, Idrisa; Stabile, Jillian; Gaitan, Brandon; Arnau Del Valle, Carla; Baumiller, Kaylin; Gaur, Anandita; Chiou, Wen-An; Karim,Baktiar; Connolly, Nina; Robey, Robert W; Woodworth, Graeme F; Gottesman, Michael M; Huang, Huang-Chiao
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, Mar 06; e2302872.
  1. 23.   A Comprehensive Investigation of Active Learning Strategies for Conducting Anti-Cancer Drug Screening
  2. Vasanthakumari, Priyanka; Zhu, Yitan; Brettin, Thomas; Partin, Alexander; Shukla, Maulik; Xia, Fangfang; Narykov, Oleksandr; Weil,Michael; Stevens, Rick L
  3. Cancers. 2024, Jan 26; 16(3):
  1. 24.   Inhibition of Plasmodium falciparum plasmepsins by drugs targeting HIV-1 protease: A way forward for antimalarial drug discovery
  2. Mishra, Vandana; Deshmukh, Anuradha; Rathore, Ishan; Chakraborty, Satadru; Patankar, Swati; Gustchina,Alla; Wlodawer,Alexander; Yada, Rickey Y; Bhaumik, Prasenjit
  3. Current Research in Structural Biology. 2024, Jan 17; 7: 100128.
  1. 25.   Quantitation of Active Pharmaceutical Ingredients in Polymeric Drug Products Using Elemental Analysis
  2. Xu,Jie; Hu, Yingwen; Clogston,Jeffrey
  3. Methods in Molecular Biology (Clifton, N.J.). 2024 2789: 35-43.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel